Lyell Immunopharma, Inc. · NASDAQ:LYEL

Seely Lynn sold 545 Lyell Immunopharma, Inc. shares (Form 4)

Traded Nov 10, 2026 · Filed Nov 12, 2026

On Nov 10, 2026, Seely Lynn (Director, President and CEO) sold 545 Lyell Immunopharma, Inc. shares at US$15.93 for US$8,682, leaving 63,354 shares. Filed Nov 12, 2026 (Form 4).

Sold
545 shares
Price
US$15.93
Value
US$8,682
Holding after
63,354 shares
Trading plan
No
Role
Director, President and CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 10, 2026Common StockSale545US$15.9363,354Direct

Source

Download original · View original at SEC

Related